Cara Therapeutics (CARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CARA | AMGN | VRTX | REGN | GILD |
| Company | Cara Therapeutics | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.3390 | 333.23 | 497.00 | 1,075.35 | 72.89 |
| High | 0.3500 | 336.35 | 498.77 | 1,078.71 | 73.32 |
| Low | 0.3310 | 332.47 | 491.52 | 1,064.95 | 72.02 |
| Last | 0.3490 | 335.80 | 494.61 | 1,072.89 | 72.52 |
| Change | +0.0045 | +4.51 | +3.04 | +9.29 | -0.04 |
| % Change | +1.31% | +1.36% | +0.62% | +0.87% | -0.06% |
| Volume | 265,234 | 549,193 | 396,834 | 97,020 | 1,381,964 |
| 20-Day Average Volume | 1,456,469 | 2,027,794 | 1,110,481 | 415,705 | 6,299,464 |
| Previous Close | 0.3445 | 331.29 | 491.57 | 1,063.60 | 72.56 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3139 | 320.96 | 481.78 | 1,064.22 | 69.78 |
| 20-Day Raw Stochastic | 55.99% | 86.43% | 83.67% | 58.61% | 71.21% |
| 20-Day Relative Strength | 42.33% | 67.76% | 66.47% | 57.29% | 62.44% |
| Weighted Alpha | -78.30 | +41.24 | +43.32 | +41.84 | -4.90 |
| Today's Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Previous Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 64% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.42% since 07/15/24 | +1.32% since 07/15/24 | +0.52% since 07/15/24 | -1.39% since 07/15/24 | +2.18% since 07/15/24 |
| Low | 0.3236 on 07/18/24 | 328.00 on 07/16/24 | 478.78 on 07/17/24 | 1,060.74 on 07/19/24 | 70.33 on 07/16/24 |
| High | 0.3898 on 07/17/24 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,100.08 on 07/16/24 | 74.92 on 07/18/24 |
| 1-Month | |||||
| %Chg | +23.86% since 06/21/24 | +8.55% since 06/21/24 | +5.27% since 06/21/24 | +1.32% since 06/21/24 | +2.38% since 06/21/24 |
| Low | 0.2580 on 06/28/24 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 66.01 on 07/05/24 |
| High | 0.4100 on 07/11/24 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 3-Month | |||||
| %Chg | -53.03% since 04/22/24 | +23.03% since 04/22/24 | +23.38% since 04/22/24 | +18.54% since 04/22/24 | +8.07% since 04/22/24 |
| Low | 0.2400 on 06/20/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 0.8700 on 05/16/24 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 6-Month | |||||
| %Chg | -38.59% since 01/22/24 | +7.85% since 01/22/24 | +12.11% since 01/22/24 | +13.18% since 01/22/24 | -7.75% since 01/22/24 |
| Low | 0.2400 on 06/20/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 1.1500 on 03/04/24 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 81.06 on 01/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,836 | 177,715,552 | 126,851,120 | 117,193,824 | 90,399,088 |
| Shares Outstanding, K | 54,676 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 20,970,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -118,510,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 2,140,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -30,700,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 0.69 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.56 on 05/13/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 08/05/24 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.77 | 32.41 | 28.76 | 18.24 |